yes, that's been a good one on pullbacks.. great buying opp i think it was 3 days ago - at the open it was off about .40...straight up from there
i agree..i bot tasr at 13.5 and sold very early.i'm more of a trader..i worked for one of thelargest otc houses back in the 80s..i'm also a wharton grad..and i can smell a rotten co a mile away...if this did get 3 recs and is only up a point, what's going to move it now? only earnings...we'll see about that lol
i like mdgn on this pullback...bought a bit today and would double up around 6.65 - the 200dma...huge insider buying,,ceo sol barrer..upcoming conference...sell-off on trial results, which were good
called up mgmt, heard a bunch of lies...you should've heard the c.c..."We're SOOOO close to signing a big contracts with out of country companies - one is basically done - all we have to do is sign.." this was the theme for idk how long...did anything ever materialize, except for mgmt lining their pockets? NOTHING. why? they have no up-to-date products and never will.. Look at tasr - every day they're signing contracts...this pos never will..oh yeah, they'll sell 200k worth here or there; that'll be it...did u happen to notice the options that were granted to all the employees..take a look at the form 4s from a week ago lol...just coincidence that r7r comes out with this ludicrous target today.. the Street knows it's a joke...24 dollar target, mkt up 200 and the stock is 15? That's the best Rodman can do for it lol.. Company is worth 2 dollars.....gl with it....the co. is only as good as its products and mgtmt - neither or which measures up
yeah, i agree it's going to go higher..lower first though, of course...i think they've run out of news for now and put it all out to milk the secondary..
do you really think with 4mm in the bank it's going to be another 7 months before a secondary, especially when the stock is up 100 percent in two days?
100 percent gain in two days and they aren't in phase 1 trials yet? idk - i'm pretty sure u can buy this one cheaper, esp after the secondary which will dilute by 50%
short on cash and not even in trials yet...